Dariohealth CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
DRIO
Dariohealth CORPNantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, has disclosed a 9.99% beneficial ownership stake in DarioHealth Corp. as of December 31, 2025.
NASDAQ
DRIO
Dariohealth CORPCraig Kallman 2015 Living Trust and Craig Kallman report a 9.99% passive beneficial ownership in DarioHealth Corp. common stock.
NASDAQ
DRIO
Dariohealth CORPNantahala Capital Management, LLC and its managing members disclosed a 9.99% beneficial ownership stake in DarioHealth Corp. common stock.
NASDAQ
DRIO
Dariohealth CORPNantahala Capital Partners Limited Partnership has amended its Schedule 13G filing, reporting a beneficial ownership of 4.5912% in DarioHealth Corp., down from a previous stake above 5%.
NASDAQ
DRIO
Dariohealth CORPTasso Partners, LLC and Dana Carrera have filed an amended Schedule 13G, reporting a combined beneficial ownership of 9.99% in DarioHealth Corp. common stock and pre-funded warrants.
NASDAQ
DRIO
Dariohealth CORPTitan Trust 2024 I has reported the complete disposition of its 2.5 million pre-split shares in DarioHealth Corp. during Q3 2025.
NASDAQ
DRIO
Dariohealth CORPNantahala Capital Management and its managing members disclosed a 9.99% beneficial ownership stake in DarioHealth Corp., including shares from exercisable warrants.
NASDAQ
DRIO
Dariohealth CORPTitan Trust 2024 I has disclosed a 5.32% beneficial ownership stake in DarioHealth Corp., primarily through warrants.
NASDAQ
DRIO
Dariohealth CORPTitan Trust 2024 I has reported the complete disposition of its beneficial ownership in DarioHealth Corp., reducing its stake to 0% of the common stock.
NASDAQ
DRIO
Dariohealth CORPSCHEDULE 13G/A: Tasso Partners and Dana Carrera Update Beneficial Ownership in DarioHealth Corp. to 6.85% and 7.94% Respectively
Tasso Partners, LLC and Dana Carrera have filed an amended Schedule 13G, disclosing their updated beneficial ownership stakes in DarioHealth Corp. common stock as of March 31, 2025.
NASDAQ
DRIO
Dariohealth CORPNantahala Capital Partners Limited Partnership has filed a Schedule 13G, reporting a passive beneficial ownership of 5.7771% in DarioHealth Corp.'s common stock as of February 27, 2025.
NASDAQ
DRIO
Dariohealth CORPNantahala Capital Management, along with its principals Wilmot B. Harkey and Daniel Mack, reported a beneficial ownership of 9.99% in DarioHealth Corp. common stock as of December 31, 2024.
NASDAQ
DRIO
Dariohealth CORPSolid Financial LLC has filed an amended Schedule 13G, reporting a 5.6% beneficial ownership stake in DarioHealth Corp.'s common stock as of December 9, 2024.
NASDAQ
DRIO
Dariohealth CORPSCHEDULE 13G/A: Solid Financial LLC Amends SEC Filing, Clarifying Passive Stake in DarioHealth Corp.
Solid Financial LLC has filed an amended Schedule 13G, correcting its filing rule and confirming a 4.6% passive ownership stake in DarioHealth Corp.
NASDAQ
DRIO
Dariohealth CORPSCHEDULE 13G/A: Solid Financial LLC Discloses 4.64% Stake in DarioHealth Corp.
Solid Financial LLC has filed an amended Schedule 13G, revealing a beneficial ownership of 4.64% of DarioHealth Corp.'s common stock as of December 31, 2024.
NASDAQ
DRIO
Dariohealth CORPTitan Trust 2024 I has reported a 9.99% beneficial ownership stake in DarioHealth Corp., primarily through common stock and warrants, as detailed in an amended Schedule 13G filing.
NASDAQ
DRIO
Dariohealth CORPTitan Trust 2024 I has reported a beneficial ownership of 7.69% in DarioHealth Corp., primarily through the cashless exercise of warrants.